MDGL Annual Working Capital
$518.73 M
+$273.26 M+111.32%
31 December 2023
Summary:
As of January 23, 2025, MDGL annual working capital is $518.73 million, with the most recent change of +$273.26 million (+111.32%) on December 31, 2023. During the last 3 years, it has risen by +$280.13 million (+117.40%). MDGL annual working capital is now at all-time high.MDGL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Quarterly Working Capital
$885.82 M
-$80.75 M-8.35%
30 September 2024
Summary:
As of January 23, 2025, MDGL quarterly working capital is $885.82 million, with the most recent change of -$80.75 million (-8.35%) on September 30, 2024. Over the past year, it has dropped by -$80.75 million (-8.35%). MDGL quarterly working capital is now -8.35% below its all-time high of $966.57 million, reached on June 30, 2024.MDGL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +111.3% | -8.3% |
| 3 y3 years | +117.4% | -8.3% |
| 5 y5 years | +8.8% | -8.3% |
MDGL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +166.2% | -8.3% | +1422.2% |
| 5 y | 5-year | at high | +166.2% | -8.3% | +1422.2% |
| alltime | all time | at high | +1160.5% | -8.3% | +1162.7% |
Madrigal Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $885.82 M(-8.4%) |
| June 2024 | - | $966.57 M(+0.7%) |
| Mar 2024 | - | $959.61 M(+85.0%) |
| Dec 2023 | $518.73 M(+111.3%) | $518.73 M(+282.0%) |
| Sept 2023 | - | $135.80 M(-32.7%) |
| June 2023 | - | $201.89 M(-13.3%) |
| Mar 2023 | - | $232.94 M(-5.1%) |
| Dec 2022 | $245.47 M(+26.0%) | $245.47 M(+321.8%) |
| Sept 2022 | - | $58.19 M(-55.4%) |
| June 2022 | - | $130.54 M(-9.7%) |
| Mar 2022 | - | $144.53 M(-25.8%) |
| Dec 2021 | $194.85 M(-18.3%) | $194.85 M(-16.6%) |
| Sept 2021 | - | $233.63 M(-13.3%) |
| June 2021 | - | $269.36 M(+3.9%) |
| Mar 2021 | - | $259.25 M(+8.7%) |
| Dec 2020 | $238.61 M(-42.5%) | $238.61 M(-17.2%) |
| Sept 2020 | - | $288.24 M(-15.6%) |
| June 2020 | - | $341.33 M(-11.1%) |
| Mar 2020 | - | $383.78 M(-7.5%) |
| Dec 2019 | $415.07 M(-12.9%) | $415.07 M(-5.6%) |
| Sept 2019 | - | $439.86 M(-3.6%) |
| June 2019 | - | $456.47 M(-2.5%) |
| Mar 2019 | - | $467.93 M(-1.9%) |
| Dec 2018 | $476.76 M(+162.0%) | $476.76 M(-1.2%) |
| Sept 2018 | - | $482.66 M(-0.7%) |
| June 2018 | - | $485.84 M(+174.6%) |
| Mar 2018 | - | $176.91 M(-2.8%) |
| Dec 2017 | $181.96 M(+399.8%) | $181.96 M(+235.7%) |
| Sept 2017 | - | $54.20 M(-11.9%) |
| June 2017 | - | $61.51 M(+78.6%) |
| Mar 2017 | - | $34.45 M(-5.4%) |
| Dec 2016 | $36.41 M(-174.4%) | $36.41 M(-2.3%) |
| Sept 2016 | - | $37.28 M(-10.1%) |
| June 2016 | - | $41.47 M(-5.7%) |
| Mar 2016 | - | $43.96 M(-189.9%) |
| Dec 2015 | -$48.91 M | -$48.91 M(-182.1%) |
| Sept 2015 | - | $59.59 M(-12.4%) |
| June 2015 | - | $68.02 M(+44.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $47.05 M(-31.3%) |
| Dec 2014 | $68.46 M(+14.0%) | $68.46 M(-23.3%) |
| Sept 2014 | - | $89.23 M(+9.3%) |
| June 2014 | - | $81.66 M(+70.0%) |
| Mar 2014 | - | $48.03 M(-20.0%) |
| Dec 2013 | $60.03 M(-22.9%) | $60.03 M(+108.4%) |
| Sept 2013 | - | $28.81 M(-44.3%) |
| June 2013 | - | $51.77 M(-31.3%) |
| Mar 2013 | - | $75.32 M(-3.3%) |
| Dec 2012 | $77.90 M(+209.9%) | $77.90 M(+110.7%) |
| Sept 2012 | - | $36.98 M(+35.7%) |
| June 2012 | - | $27.24 M(-35.7%) |
| Mar 2012 | - | $42.35 M(+68.5%) |
| Dec 2011 | $25.14 M(-27.7%) | $25.14 M(-28.0%) |
| Sept 2011 | - | $34.91 M(-27.8%) |
| June 2011 | - | $48.37 M(+106.3%) |
| Mar 2011 | - | $23.44 M(-32.6%) |
| Dec 2010 | $34.78 M(+23.8%) | $34.78 M(-12.7%) |
| Sept 2010 | - | $39.85 M(+7.4%) |
| June 2010 | - | $37.11 M(-19.1%) |
| Mar 2010 | - | $45.89 M(+63.3%) |
| Dec 2009 | $28.11 M(-51.5%) | $28.11 M(-20.1%) |
| Sept 2009 | - | $35.18 M(-142.2%) |
| June 2009 | - | -$83.35 M(-293.7%) |
| Mar 2009 | - | $43.02 M(-25.7%) |
| Dec 2008 | $57.90 M(-39.8%) | $57.90 M(+0.3%) |
| Sept 2008 | - | $57.71 M(-4.2%) |
| June 2008 | - | $60.26 M(-25.4%) |
| Mar 2008 | - | $80.75 M(-16.1%) |
| Dec 2007 | $96.22 M(+166.7%) | $96.22 M(+162.3%) |
| Sept 2007 | - | $36.69 M(-26.7%) |
| June 2007 | - | $50.05 M(-25.4%) |
| Mar 2007 | - | $67.06 M(+85.8%) |
| Dec 2006 | $36.08 M(-25.6%) | $36.08 M(-25.5%) |
| Sept 2006 | - | $48.45 M(-0.1%) |
| Dec 2005 | $48.48 M(-57.2%) | $48.48 M(-49.1%) |
| Mar 2005 | - | $95.22 M |
| Dec 2004 | $113.15 M(+53.8%) | - |
| Dec 2003 | $73.56 M | - |
FAQ
- What is Madrigal Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual working capital year-on-year change?
- What is Madrigal Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly working capital year-on-year change?
What is Madrigal Pharmaceuticals annual working capital?
The current annual working capital of MDGL is $518.73 M
What is the all time high annual working capital for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual working capital is $518.73 M
What is Madrigal Pharmaceuticals annual working capital year-on-year change?
Over the past year, MDGL annual working capital has changed by +$273.26 M (+111.32%)
What is Madrigal Pharmaceuticals quarterly working capital?
The current quarterly working capital of MDGL is $885.82 M
What is the all time high quarterly working capital for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly working capital is $966.57 M
What is Madrigal Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, MDGL quarterly working capital has changed by -$80.75 M (-8.35%)